Skip to content
Medical Health Aged Care

A mother’s diet can protect her grandchildren’s brains: genetic model study

Monash University 2 mins read

Mothers who eat apples and herbs in early pregnancy could be protecting the brain health of their children and grandchildren, a Monash University study using genetic models has found.

 

The discovery is part of a project that found a mother’s diet can affect not just her child’s brain but also those of her grandchildren.

 

Published in Nature Cell Biology, the Monash Biomedicine Discovery Institute study found that certain foods could help protect against the deterioration of brain function.

 

More specifically, the study used roundworms (Caenorhabditis elegans) as the genetic model because many of their genes are also found conserved in humans, allowing insights into human cells.

 

The researchers found that a molecule present in apples and herbs (basil, rosemary, thyme, oregano, and sage) helped reduce the breakdown of communication cables needed for the brain to work properly.

 

Senior author Professor Roger Pocock and his team were investigating nerve cells in the brain that connect and communicate with each other through about 850,000 kilometres of cables called axons. For axons to function and survive, essential materials need to be transported along an internal structure that contains microtubules.

 

Professor Pocock explained that a malfunction that caused the axons to become fragile led to brain dysfunction and neurodegeneration. 

 

He said his team used a genetic model with fragile axons that break as animals age. “We asked whether natural products found in the diet can stabilise these axons and prevent breakage,” he explained.

 

“We identified a molecule found in apples and herbs (ursolic acid) that reduces axon fragility. How? We found that ursolic acid causes a gene to turn on that makes a specific type of fat. This particular fat also prevented axon fragility as animals age by improving axon transport and therefore its overall health.”

 

Professor Pocock said this type of fat, known as a sphingolipid, had to travel from the mother’s intestine, where food is digested, to eggs in the uterus for it to protect axons in the next generation. He said while the results were promising, they still need to be confirmed in humans.

 

“This is the first time that a lipid/fat has been shown to be inherited,” he said. “Further, feeding the mother the sphingolipid protects the axons of two subsequent generations. This means a mother’s diet can affect not just their offspring’s brain but potentially subsequent generations.  Our work supports a healthy diet during pregnancy for optimal brain development and health.”


Read the full paper published in Nature Cell Biology, titled An Intestinal Sphingolipid Confers Intergenerational Neuroprotection

DOI: 10.1038/s41556-023-01195-9


For media enquiries please contact:

Monash University

Cheryl Critchley - Communications Manager (medical)
E:
[email protected]

T: +61 (0) 418 312 596

 

For more Monash media stories, visit our news and events site 


For general media enquiries please contact:
Monash Media
E: 
[email protected]
T: +61 (0) 3 9903 4840

About the Monash Biomedicine Discovery Institute

Committed to making the discoveries that will relieve the future burden of disease, the Monash Biomedicine Discovery Institute (BDI) at Monash University brings together more than 120 internationally-renowned research teams. Spanning seven discovery programs across Cancer, Cardiovascular Disease, Development and Stem Cells, Infection, Immunity, Metabolism, Diabetes and Obesity, and Neuroscience, Monash BDI is one of the largest biomedical research institutes in Australia. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.

 

 

***ENDS***

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.